Pharmaceuticals
Novartis splits drugs business into two, pharma chief to leave | ReutersNovartis is splitting its pharmaceuticals division into two business units, one focused on cancer and the second on other drugs, while switching out its current pharma head in the second high-profile management reshuffle this year.
Valeant said to weigh sale of skin, cancer drugs to cut debt | Bloomberg
Valeant Pharmaceuticals is exploring the sale of some of its smaller cosmetic and pharmaceutical assets, according to people familiar with the matter, as the Canadian drugmaker scrambles to raise cash and reduce debt.
Physicians
1 in 3 female doctors faces sexual harassment, survey finds | U.S. News & World ReportThirty percent of female doctors face sexual harassment on the job, new research shows. And close to three-quarters perceive gender bias at work, while two-thirds said they have actually experienced it, the researchers added.
Safety, quality and clinical practice
Surgery surprise: Small rural hospitals may be safer, less expensive for common operations | Medical XpressThey may be in small towns. They may only have a couple of surgeons. But for common operations, they may be safer and less expensive than their larger cousins, a new study finds.
Half of heart attacks might be 'silent' | U.S. News & World Report
As many as half of all heart attacks may be "silent" -- without the typical crushing chest pain, shortness of breath and cold sweats, new study findings suggest.
